SCHEMBL18709642

SCHEMBL18709642

NS(=O)(=O)C1CC(F)(F)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16499846 0.74 APLNR (0.32) APLNR
SCHEMBL26556218 0.72 APLNR (0.31) APLNR
SCHEMBL9991970 0.72 TSHR (0.39) APLNR
SCHEMBL25001313 0.72 APLNR (0.39) APLNR
SCHEMBL1933726 0.72 APLNR (0.31) APLNR
SCHEMBL1933922 0.70 TSHR (0.37) APLNR
SCHEMBL21904698 0.69 APLNR (0.35) APLNR
SCHEMBL26869804 0.69
SCHEMBL23183520 0.69 APLNR (0.33) APLNR
SCHEMBL19115012 0.67 JAK2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150600-B1 DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR QILU PHARMACEUTICAL CO LTD (CN) 2018-06-27 EP disclosed
EP-3150600-A1 DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR Medshine Discovery Inc. (CN) 2017-04-05 EP disclosed